Apimeds Pharmaceuticals Announces Inscobee Violates Merger Agreement; Prepares Emergency Action To Be Filed In Delaware Court Of Chancery

Apimeds Pharmaceuticals (NYSE American: APUS) announced that Inscobee Inc. has violated their merger agreement by attempting a hostile takeover of the company's Board of Directors. On March 20, 2026, Inscobee filed an amendment claiming to have removed all four sitting directors of APUS and replaced them with three new directors without proper authorization. Apimeds is preparing to file an emergency action in the Delaware Court of Chancery in response to this situation.